PHOTO
- To mark VITALDENT's 30th anniversary, Dr. Gustavo Camañas presented this test to all the company's professionals at its annual convention
- The Bacteriological Genetic Test will allow to detect the periodontal bacteria’s DNA being able to identify its different types to prevent and to approach with more effective treatments diseases like gingivitis, periodontitis and even halitosis
Madrid. VITALDENT, a leading group in the oral health sector, has signed an agreement with Spiral, a company specialized in genetic analysis and technology, to distribute the Bacteriological Genetic Test and the Human Papilloma Virus (HPV) genetic analysis in all its clinics. On the occasion of VITALDENT's 30th anniversary, Dr. Gustavo Camañas, VITALDENT's Medical Director, presented to his professionals’ network this latest innovation that allows, besides detecting the DNA of periodontal bacteria, to prevent diseases such as gingivitis or periodontitis. Spiral´s Human Papilloma Virus (HPV) genetic analysis detects the presence of the most frequent high and low risk subtypes.
Dr. Gustavo Camañas stated during the annual convention that "one of the most common oral health problems in the population is periodontal diseases or infections, those that damage the gums or the bone that supports them. A condition that, if not treated properly, can lead to the loss of teeth and even affect the health system. Numerous studies have linked periodontal diseases to heart disease, diabetes and even Alzheimer's disease”.
Thus, thanks to this new painless test, VITALDENT’s professionals can identify, classify and quantify the 16 most involved periodontal bacteria in the appearance of periodontal disease through the study of the bacteria’s DNA. Therefore as a result of this Bacteriological Test, it is possible to identify the types of bacteria present in the patient's mouth, their quantity, as well as, recommend the best medications for the most favourable result. Additionally it is also possible to genetically detect these bacteria and predict whether the patient is infected before he or she even develops the disease, especially in patients with a genetic history of pyorrhea.
Furthermore, beyond periodontal diseases such as gingivitis and periodontitis, patients suffering from halitosis can also benefit from the advantages offered by this test.
In the words of Francisco Tercero-Mora, Spiral’s CEO, "This collaboration guarantees, thanks to the six years of experience that Spiral has and being one of the main companies in genetic analysis and technology, that all VITALDENT’s clinics can provide their patients with the highest quality and safety when it comes to testing, as well as helping save lives and introducing medicine into the Oral Health sector”.
VITALDENT thus continues to work on its commitment to research and innovation in all its processes, products and treatments, and begins its journey towards microgenetic dentistry with the aim of achieving dental excellence for the benefit of its patients.
About VITALDENT
With 30 years of activity in the market, Vitaldent is currently the leading Spanish group in the dental health sector. Vitaldent’s clinics provide a comprehensive diagnosis to their patients, taking care of their oral health with innovative treatments and high quality care. Vitaldent's mission is to make quality dentistry accessible to society with the most advanced technology, the best treatments and professionals with proven experience.
The company has attended more than 7.5 million patients over its 30 years. With a turnover of nearly 300 million euros, it employs 2,500 professionals and has more than 1,400 dentists working with it.
Advent International, one of the largest and most experienced private equity firms in the world, is the majority shareholder in Vitaldent. Advent International has been operating in Spain for almost 30 years and has 6 professionals responsible for making investments in the country and 80 employees in Europe.
About Spiral
Spiral, with headquarters in the Madrid Science Park, Spain, is an international company specialized in genetic analysis and technology. Spiral has extensive experience in the field of research and development of multiple DNA analysis tests. Operating in Europe, Middle East, Asia and in LatAm through strategic partnerships.
Spiral has a company created in Abu Dhabi to serve the UAE and the GCC markets.
Spiral’s main partners in UAE are:
Her Highness Sheikha Fatima Bint Mohammed Bin Saqr Al Qassimi - member of the Royal Family of Ras al-Khaimah.
Internationally recognized business owner and investor H.E. Sulaiman Al-Fahim.
According to the ‘Arabian Business Magazine’ ranking, Al-Fahim is the fourth most important Arabian in the world.
FOR MORE INFORMATION:
VITALDENT - Macarena Ramírez
comunicacion@vitaldent.com - Tel: +34 91 375 65 60
LLYC – Carmen Carvajal
ccarvajal@llorenteycuenca.com - Tel: +34 91 563 77 22
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
